Search results
The bird flu vaccine is made with eggs. That has scientists worried.
CBS News· 13 hours ago"It's almost comical to be using a 1940s technology for a 21st-century pandemic," said Rick Bright,...
This Biotech Stock is a “Strong Buy” According to Raymond James
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
The Motley Fool via AOL· 5 days ago(The long-term annual average return of the S&P 500 is around 10%.) If you're looking for very promising stocks that can help you build wealth in the years ahead, here are three to consider.
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 6 hours agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 8 hours agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
1 High-Yield ETF Could Turn $400 Per Month Into $50,000 In Annual Dividend Income | The Motley Fool
The Motley Fool· 4 days agoBuilding a portfolio of dividend stocks that can replace all or some of your paycheck is a big goal...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 6 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Chinese CDMO takes over Pfizer’s UK facility; Serum Institute ships malaria vaccine to Africa
Endpoints News· 6 days agoAsymchem Laboratories will take over operations at Pfizer’s API facility in Sandwich, UK, which the pharma company previously said it would downsize. The facility is Asymchem ...
BioNTech gets $145 million funding for African vaccine plants
Reuters via AOL· 10 hours agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
Pfizer's $1.5B cuts; Biogen's $1.15B buyout; AstraZeneca's $80B ambition; RNA startup merger; and...
Endpoints News· 5 days agoWant this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. Whether you will be in San Diego for BIO, we hope you will join ...